DiviDrip · TTRX

TTRX — Turn Therapeutics Inc.

TTRX is Turn Therapeutics Inc. (Healthcare) — a non-dividend-paying stock. Trading at $9.80. Market cap: $306M. Capital Quality Rank: 28/100 — Capital destroyer.

Stock snapshot

Price$9.80
Market cap$306M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)28 / 100 · Capital destroyer
Altman Z-score zoneSafe

About TTRX

Turn Therapeutics Inc is a clinical-stage biotechnology and medical device development company built around its proprietary platform technology called PermaFusion designed to enhance drug performance. The company is developing non-systemic, non-biologic topical immunomodulators for inflammatory skin disease. Its program, GX-03, is being studied for moderate-to-severe eczema based on preclinical evidence of cytokine inhibition and reduced eczema severity, as well as a favorable real-world tolerability record from prior cleared medical device indications for the same formula. GX-03 is currently being evaluated in an ongoing, randomized, double-blind, vehicle-controlled clinical study designed to assess its potential as a topical treatment for moderate-to-severe eczema.

Listed2025Employees2HQWestlake Village, CASectorHealthcareWebsiteturntherapeutics.com

Related non-dividend companies

Other non-dividend stocks investors research alongside TTRX. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is TTRX's current stock price?

TTRX (Turn Therapeutics Inc.) is currently trading at $9.80.

Does TTRX pay a dividend?

TTRX (Turn Therapeutics Inc.) does not currently pay a regular dividend.

What is TTRX's Capital Quality Rank?

TTRX has a Capital Quality Rank of 28/100 — Capital destroyer. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track TTRX in DiviDrip

Add TTRX to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-04. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow